WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announces that its CorPath technology was used to conduct the first-in-human (FIH) Telerobotic Intervention Study, December 4 and 5, 2018, in India. This study represents the world’s first percutaneous coronary intervention (PCI) conducted from […]
Other News
MyoKardia to Present at the BMO 2018 Prescriptions for Success Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced that Taylor Harris, Chief Financial Officer, will present at the BMO 2018 Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018, […]
Avinger Announces Commercial Launch in Australia
REDWOOD CITY, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD), today announced the commercial launch of its Pantheris image-guided atherectomy system in Australia. Avinger […]
BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
Santa Monica, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Mayo Clinic to […]
Cardiologs Co-Founder & CEO Named to MIT Technology Review’s Innovators Under 35 and BNP Paribas European Innovator of the Year
PARIS, Dec. 5, 2018 /PRNewswire/ — Cardiologs, a medtech company transforming cardiac diagnostics using medical-grade artificial intelligence (AI) and cloud technology, announced today that co-founder and CEO, Yann Fleureau, has been named one of MIT Technology Review’s Innovators Under 35 Europe 2018. He was honored during an award ceremony in Paris on December 4, 2018. Additionally, Yann Fleureau has […]
World Congress of Cardiology & Cardiovascular Health 2018 Opens in Dubai
DUBAI, UAE, December 5, 2018 /PRNewswire/ — Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact on cardiovascular health have never been greater World […]
P. (Laxmin) Laxminarain Appointed to Millar’s Board of Directors
HOUSTON, Dec. 5, 2018 /PRNewswire/ — Millar, Inc., medical device manufacturer and OEM pressure sensor integration partner, today announced the appointment of P. (Laxmin) Laxminarain to the company’s Board of Directors. Mr. Laxminarain’s successful track record in the medical device industry for over 30 years will provide Millar a significant upgrade in governance talent […]
Hitachi Medical Systems Europe Introduces the Third Generation of Non-invasive Intracardiac Blood Flow Visualization Technology, at EuroEcho Imaging 2018
ZUG, Switzerland, December 5, 2018 /PRNewswire/ — Premium cardiac and vascular imaging rises to a new standard as Hitachi Medical Systems Europe introduces the next level of intelligent Vector Flow Mapping (iVFM) at EuroEcho Imaging 2018 in Milan, Italy, December 5, 2018. Increasing in popularity, the third generation of non-invasive intracardiac blood flow visualization technology provides unique information about the intraventricular vortex and […]
MEDTRONIC STATEMENT REGARDING RECENT DOJ ANNOUNCEMENT
DUBLIN – December 4, 2018 – Medtronic plc has agreed with the United States Department of Justice (DOJ) to resolve three claims against Covidien LP and ev3, Inc., now part of Medtronic. Regarding a matter concerning the Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry, […]
Orchestra BioMed™ Appoints C. Evan Ballantyne as Chief Financial Officer
NEW HOPE, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, announced today that it has appointed Evan Ballantyne as its Chief Financial Officer (CFO). Mr. Ballantyne is an experienced financial and […]



